FLT3 and acute myeloid leukemia: H19 is upregulated in AML patients compared to healthy donors and correlates with White Blood Cell (WBC) count, intermediate karyotype classifications, FLT3/ITD and DNMT3a recurrent mutations in AML patients [98].